Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC705321382;21383;21384 chr2:178724102;178724101;178724100chr2:179588829;179588828;179588827
N2AB673620431;20432;20433 chr2:178724102;178724101;178724100chr2:179588829;179588828;179588827
N2A580917650;17651;17652 chr2:178724102;178724101;178724100chr2:179588829;179588828;179588827
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Ig-55
  • Domain position: 10
  • Structural Position: 13
  • Q(SASA): 0.3668
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/P rs727504741 -0.361 0.859 N 0.539 0.405 0.478222008075 gnomAD-2.1.1 7.19E-05 None None None None N None 0 0 None 3.88651E-04 1.02891E-04 None 3.93211E-04 None 0 0 2.82725E-04
T/P rs727504741 -0.361 0.859 N 0.539 0.405 0.478222008075 gnomAD-3.1.2 1.31E-05 None None None None N None 0 0 0 0 0 None 0 0 0 2.07039E-04 4.78011E-04
T/P rs727504741 -0.361 0.859 N 0.539 0.405 0.478222008075 gnomAD-4.0.0 4.03024E-05 None None None None N None 0 0 None 3.71848E-04 2.90062E-04 None 0 0 4.24005E-06 3.62534E-04 4.80769E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.079 likely_benign 0.0719 benign -0.613 Destabilizing 0.22 N 0.488 neutral D 0.528747016 None None N
T/C 0.3764 ambiguous 0.3408 ambiguous -0.314 Destabilizing 0.968 D 0.541 neutral None None None None N
T/D 0.3321 likely_benign 0.3034 benign -0.006 Destabilizing 0.726 D 0.497 neutral None None None None N
T/E 0.2561 likely_benign 0.2283 benign -0.048 Destabilizing 0.567 D 0.483 neutral None None None None N
T/F 0.1833 likely_benign 0.1677 benign -0.925 Destabilizing 0.567 D 0.592 neutral None None None None N
T/G 0.2445 likely_benign 0.2144 benign -0.812 Destabilizing 0.726 D 0.539 neutral None None None None N
T/H 0.2278 likely_benign 0.2018 benign -1.186 Destabilizing 0.006 N 0.465 neutral None None None None N
T/I 0.1136 likely_benign 0.0998 benign -0.193 Destabilizing 0.001 N 0.296 neutral N 0.503811286 None None N
T/K 0.1727 likely_benign 0.1661 benign -0.564 Destabilizing 0.726 D 0.501 neutral None None None None N
T/L 0.1017 likely_benign 0.0899 benign -0.193 Destabilizing 0.026 N 0.549 neutral None None None None N
T/M 0.0928 likely_benign 0.0812 benign 0.113 Stabilizing 0.567 D 0.544 neutral None None None None N
T/N 0.1305 likely_benign 0.1257 benign -0.387 Destabilizing 0.497 N 0.439 neutral D 0.526789592 None None N
T/P 0.2273 likely_benign 0.1997 benign -0.302 Destabilizing 0.859 D 0.539 neutral N 0.520459716 None None N
T/Q 0.2099 likely_benign 0.19 benign -0.596 Destabilizing 0.726 D 0.535 neutral None None None None N
T/R 0.1241 likely_benign 0.1145 benign -0.33 Destabilizing 0.726 D 0.529 neutral None None None None N
T/S 0.1066 likely_benign 0.0999 benign -0.628 Destabilizing 0.364 N 0.475 neutral D 0.532923471 None None N
T/V 0.1018 likely_benign 0.0912 benign -0.302 Destabilizing 0.026 N 0.503 neutral None None None None N
T/W 0.4858 ambiguous 0.4191 ambiguous -0.884 Destabilizing 0.968 D 0.659 neutral None None None None N
T/Y 0.2357 likely_benign 0.2095 benign -0.63 Destabilizing 0.567 D 0.593 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.